MX9205766A - COLON AND STRAIGHT CANCER TREATMENT - Google Patents

COLON AND STRAIGHT CANCER TREATMENT

Info

Publication number
MX9205766A
MX9205766A MX9205766A MX9205766A MX9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A MX 9205766 A MX9205766 A MX 9205766A
Authority
MX
Mexico
Prior art keywords
colon
cancer treatment
straight
straight cancer
treatment
Prior art date
Application number
MX9205766A
Other languages
Spanish (es)
Inventor
Randall Keith Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9205766A publication Critical patent/MX9205766A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
MX9205766A 1991-12-10 1992-10-08 COLON AND STRAIGHT CANCER TREATMENT MX9205766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80457091A 1991-12-10 1991-12-10

Publications (1)

Publication Number Publication Date
MX9205766A true MX9205766A (en) 1993-06-01

Family

ID=25189304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205766A MX9205766A (en) 1991-12-10 1992-10-08 COLON AND STRAIGHT CANCER TREATMENT

Country Status (7)

Country Link
EP (1) EP0661977A1 (en)
JP (1) JPH07501818A (en)
AU (1) AU2394392A (en)
CA (1) CA2125293A1 (en)
MX (1) MX9205766A (en)
PT (1) PT100948A (en)
WO (1) WO1993011770A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
DE69409633T2 (en) * 1993-01-15 1998-08-06 The Stehlin Foundation For Cancer Research, Houston, Tex. TRANSDERMAL TREATMENT OF CANCER WITH WATER-INSOLUBLE S-CAMTOTHECIN WITH CLOSED LACTORING
US6291425B1 (en) * 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
ES2371171B1 (en) * 2010-06-08 2012-11-16 Consejo Superior De Investigaciones Científicas (Csic) CAMPTOTECHINE DERIVATIVES AS ANTITUMOR AGENTS.
CN102477042A (en) * 2010-11-26 2012-05-30 复旦大学 10-hydroxyamptothecin derivative, and its preparation method and application
CN102659800B (en) * 2012-05-11 2014-09-03 中国药科大学 Hypoxia-activated antitumor compounds and application thereof
CN103113381B (en) * 2013-02-26 2014-12-10 大连理工大学 Serial water-soluble hydroxycamptothecine naphthenic amino alcohol derivative and preparation method and use thereof
WO2021173773A1 (en) 2020-02-25 2021-09-02 Mediboston, Inc. Camptothecin derivatives and conjugates thereof
CN117599058A (en) * 2023-03-09 2024-02-27 兰州大学 Application of camptothecine derivatives in preparation of medicines for treating bladder cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0641161B2 (en) * 1988-02-17 1994-06-01 積水化成品工業株式会社 Method for producing styrene resin foam sheet and styrene resin foam sheet for thermoforming
JPH0768403B2 (en) * 1988-12-15 1995-07-26 東洋エンジニアリング株式会社 Method of manufacturing foam
JP2756366B2 (en) * 1990-11-27 1998-05-25 松下電工株式会社 Method for producing hydrophobic airgel

Also Published As

Publication number Publication date
EP0661977A4 (en) 1994-10-20
PT100948A (en) 1994-01-31
WO1993011770A1 (en) 1993-06-24
CA2125293A1 (en) 1993-06-24
JPH07501818A (en) 1995-02-23
EP0661977A1 (en) 1995-07-12
AU2394392A (en) 1993-07-19

Similar Documents

Publication Publication Date Title
DE69120096D1 (en) Treated papers
BR9303267A (en) TWO PASTA VILLANT
FI931842A (en) ELEKTRISK LEDANDE PIGMENT
FI930487A0 (en) NYTT FLINGFORMIGT PIGMENT
FI922985A (en) YOUR MODIFIED SKIVFORM PIGMENT
FI931072A (en) YTMODIFIERADE PIGMENT
FI932933A0 (en) Tvaostegsraffinoer med variable intensity
FI951163A0 (en) Waste treatment
DE69031446D1 (en) IMAGE TREATMENT ARRANGEMENT
MX9205766A (en) COLON AND STRAIGHT CANCER TREATMENT
GB9303210D0 (en) Cancer treatment
DK206391A (en) SLUDGE TREATMENT
DE69218229D1 (en) DESULFURATION TREATMENT
DE69125187D1 (en) WASTE TREATMENT
DE69101652D1 (en) Treatment furnace.
MX9200725A (en) ESOPHAGEAL CANCER TREATMENT. ESOPHAGEAL CANCER TREATMENT.
GB2242372B (en) Sewage treatment
DE69125179D1 (en) WASTEWATER TREATMENT
FI945200A0 (en) wastewater treatment
KR970000602A (en) Antibacterial treatment of printed matter
DE69114853D1 (en) WASTEWATER TREATMENT.
NO922518D0 (en) coagulants
KR950003749U (en) Wastewater treatment
GB9218713D0 (en) Gastrointestinal cancer treatment
GB9108786D0 (en) Effluent treatment